MedTrace Logo

Prognostic Significance of Bioscore in Nonmetastatic Breast Cancer

NCT03638219 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 317

Last updated 2021-03-18

No results posted yet for this study

Summary

assess the validity of applying the bioscore system to predict the disease-free survival (The percentage of people in a study or treatment group who have not experienced disease relapse in a defined period of time.) in breast cancer patients presenting to our

Conditions

Interventions

OTHER

Data collection about eligible patients presented to our department from 2015 to 2018. Then follow up till 2020.

Data collection, follow up and bioscore calculation at the end of study

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-01
Primary Completion
2020-09-30
Completion
2020-10-16

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03638219 on ClinicalTrials.gov